/Companies

NXI Therapeutics

5 known investors

Find your way into NXI Therapeutics

Sign up to see every warm intro you have to NXI Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the NXI Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.

Founders & leadership

RJRajesh Jayachandran, MD PhD
Rajesh Jayachandran, MD PhDFounder

Investors · 5

Also in the syndicate · 2

BaseLaunchJFG Life Sciences Foundationlead

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does NXI Therapeutics do?
Immunotherapies for T cell-mediated autoimmune conditions via modulation of coronin 1; spin-off from the University of Basel.
Who founded NXI Therapeutics?
NXI Therapeutics was founded by Rajesh Jayachandran, MD PhD.
Who are NXI Therapeutics's investors?
NXI Therapeutics's investors include BioMedPartners, Kickfund, Venture Kick.